Copyright Reports & Markets. All rights reserved.

Global and China Hospital-acquired Infection Diagnostics Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Hospital-acquired Infection Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Instrument and Reagents
    • 1.2.3 Consumables
  • 1.3 Market by Application
    • 1.3.1 Global Hospital-acquired Infection Diagnostics Market Share by Application: 2020 VS 2026
    • 1.3.2 Hospital
    • 1.3.3 Clinics
    • 1.3.4 Ambulatory Surgery Centers (ASC)
    • 1.3.5 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Hospital-acquired Infection Diagnostics Market Perspective (2015-2026)
  • 2.2 Global Hospital-acquired Infection Diagnostics Growth Trends by Regions
    • 2.2.1 Hospital-acquired Infection Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Hospital-acquired Infection Diagnostics Historic Market Share by Regions (2015-2020)
    • 2.2.3 Hospital-acquired Infection Diagnostics Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Hospital-acquired Infection Diagnostics Players by Market Size
    • 3.1.1 Global Top Hospital-acquired Infection Diagnostics Players by Revenue (2015-2020)
    • 3.1.2 Global Hospital-acquired Infection Diagnostics Revenue Market Share by Players (2015-2020)
  • 3.2 Global Hospital-acquired Infection Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Hospital-acquired Infection Diagnostics Revenue
  • 3.4 Global Hospital-acquired Infection Diagnostics Market Concentration Ratio
    • 3.4.1 Global Hospital-acquired Infection Diagnostics Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Hospital-acquired Infection Diagnostics Revenue in 2019
  • 3.5 Key Players Hospital-acquired Infection Diagnostics Area Served
  • 3.6 Key Players Hospital-acquired Infection Diagnostics Product Solution and Service
  • 3.7 Date of Enter into Hospital-acquired Infection Diagnostics Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Hospital-acquired Infection Diagnostics Breakdown Data by Type (2015-2026)

  • 4.1 Global Hospital-acquired Infection Diagnostics Historic Market Size by Type (2015-2020)
  • 4.2 Global Hospital-acquired Infection Diagnostics Forecasted Market Size by Type (2021-2026)

5 Hospital-acquired Infection Diagnostics Breakdown Data by Application (2015-2026)

  • 5.1 Global Hospital-acquired Infection Diagnostics Historic Market Size by Application (2015-2020)
  • 5.2 Global Hospital-acquired Infection Diagnostics Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Hospital-acquired Infection Diagnostics Market Size (2015-2026)
  • 6.2 North America Hospital-acquired Infection Diagnostics Market Size by Type (2015-2020)
  • 6.3 North America Hospital-acquired Infection Diagnostics Market Size by Application (2015-2020)
  • 6.4 North America Hospital-acquired Infection Diagnostics Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Hospital-acquired Infection Diagnostics Market Size (2015-2026)
  • 7.2 Europe Hospital-acquired Infection Diagnostics Market Size by Type (2015-2020)
  • 7.3 Europe Hospital-acquired Infection Diagnostics Market Size by Application (2015-2020)
  • 7.4 Europe Hospital-acquired Infection Diagnostics Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Hospital-acquired Infection Diagnostics Market Size (2015-2026)
  • 8.2 China Hospital-acquired Infection Diagnostics Market Size by Type (2015-2020)
  • 8.3 China Hospital-acquired Infection Diagnostics Market Size by Application (2015-2020)
  • 8.4 China Hospital-acquired Infection Diagnostics Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Hospital-acquired Infection Diagnostics Market Size (2015-2026)
  • 9.2 Japan Hospital-acquired Infection Diagnostics Market Size by Type (2015-2020)
  • 9.3 Japan Hospital-acquired Infection Diagnostics Market Size by Application (2015-2020)
  • 9.4 Japan Hospital-acquired Infection Diagnostics Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Hospital-acquired Infection Diagnostics Market Size (2015-2026)
  • 10.2 Southeast Asia Hospital-acquired Infection Diagnostics Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Hospital-acquired Infection Diagnostics Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Hospital-acquired Infection Diagnostics Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 Abbott Laboratories
    • 11.1.1 Abbott Laboratories Company Details
    • 11.1.2 Abbott Laboratories Business Overview
    • 11.1.3 Abbott Laboratories Hospital-acquired Infection Diagnostics Introduction
    • 11.1.4 Abbott Laboratories Revenue in Hospital-acquired Infection Diagnostics Business (2015-2020))
    • 11.1.5 Abbott Laboratories Recent Development
  • 11.2 Advan DX
    • 11.2.1 Advan DX Company Details
    • 11.2.2 Advan DX Business Overview
    • 11.2.3 Advan DX Hospital-acquired Infection Diagnostics Introduction
    • 11.2.4 Advan DX Revenue in Hospital-acquired Infection Diagnostics Business (2015-2020)
    • 11.2.5 Advan DX Recent Development
  • 11.3 Abbott
    • 11.3.1 Abbott Company Details
    • 11.3.2 Abbott Business Overview
    • 11.3.3 Abbott Hospital-acquired Infection Diagnostics Introduction
    • 11.3.4 Abbott Revenue in Hospital-acquired Infection Diagnostics Business (2015-2020)
    • 11.3.5 Abbott Recent Development
  • 11.4 Astrazeneca PLC
    • 11.4.1 Astrazeneca PLC Company Details
    • 11.4.2 Astrazeneca PLC Business Overview
    • 11.4.3 Astrazeneca PLC Hospital-acquired Infection Diagnostics Introduction
    • 11.4.4 Astrazeneca PLC Revenue in Hospital-acquired Infection Diagnostics Business (2015-2020)
    • 11.4.5 Astrazeneca PLC Recent Development
  • 11.5 Bayer Schering Pharma LLC
    • 11.5.1 Bayer Schering Pharma LLC Company Details
    • 11.5.2 Bayer Schering Pharma LLC Business Overview
    • 11.5.3 Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Introduction
    • 11.5.4 Bayer Schering Pharma LLC Revenue in Hospital-acquired Infection Diagnostics Business (2015-2020)
    • 11.5.5 Bayer Schering Pharma LLC Recent Development
  • 11.6 Becton Dickinson And Company
    • 11.6.1 Becton Dickinson And Company Company Details
    • 11.6.2 Becton Dickinson And Company Business Overview
    • 11.6.3 Becton Dickinson And Company Hospital-acquired Infection Diagnostics Introduction
    • 11.6.4 Becton Dickinson And Company Revenue in Hospital-acquired Infection Diagnostics Business (2015-2020)
    • 11.6.5 Becton Dickinson And Company Recent Development
  • 11.7 Cepheid Inc.
    • 11.7.1 Cepheid Inc. Company Details
    • 11.7.2 Cepheid Inc. Business Overview
    • 11.7.3 Cepheid Inc. Hospital-acquired Infection Diagnostics Introduction
    • 11.7.4 Cepheid Inc. Revenue in Hospital-acquired Infection Diagnostics Business (2015-2020)
    • 11.7.5 Cepheid Inc. Recent Development
  • 11.8 Roche AG
    • 11.8.1 Roche AG Company Details
    • 11.8.2 Roche AG Business Overview
    • 11.8.3 Roche AG Hospital-acquired Infection Diagnostics Introduction
    • 11.8.4 Roche AG Revenue in Hospital-acquired Infection Diagnostics Business (2015-2020)
    • 11.8.5 Roche AG Recent Development
  • 11.9 Daiichi Sankyo
    • 11.9.1 Daiichi Sankyo Company Details
    • 11.9.2 Daiichi Sankyo Business Overview
    • 11.9.3 Daiichi Sankyo Hospital-acquired Infection Diagnostics Introduction
    • 11.9.4 Daiichi Sankyo Revenue in Hospital-acquired Infection Diagnostics Business (2015-2020)
    • 11.9.5 Daiichi Sankyo Recent Development
  • 11.10 Hologic, Inc.
    • 11.10.1 Hologic, Inc. Company Details
    • 11.10.2 Hologic, Inc. Business Overview
    • 11.10.3 Hologic, Inc. Hospital-acquired Infection Diagnostics Introduction
    • 11.10.4 Hologic, Inc. Revenue in Hospital-acquired Infection Diagnostics Business (2015-2020)
    • 11.10.5 Hologic, Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Hospital-acquired Infection Diagnostics Scope and Market Size
    Hospital-acquired Infection Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hospital-acquired Infection Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Instrument and Reagents
    Consumables

    Market segment by Application, split into
    Hospital
    Clinics
    Ambulatory Surgery Centers (ASC)
    Others

    Based on regional and country-level analysis, the Hospital-acquired Infection Diagnostics market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Hospital-acquired Infection Diagnostics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Abbott Laboratories
    Advan DX
    Abbott
    Astrazeneca PLC
    Bayer Schering Pharma LLC
    Becton Dickinson And Company
    Cepheid Inc.
    Roche AG
    Daiichi Sankyo
    Hologic, Inc.

    Buy now